Evidence map›Paper›PMID 33292691›Full record

ReviewClinical and translational allergy2020

Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies.

Jean Bousquet, Jean-Paul Cristol, Wienczyslawa Czarlewski, Josep M Anto, Adrian Martineau, Tari Haahtela, Susana C Fonseca, Guido Iaccarino, Hubert Blain, Alessandro Fiocchi and 11 more

Open access · goldAbstract readReview
In one paragraph

Review in Clinical and translational allergy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 78 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Cognitive Impairment in Multiple Sclerosis.Bioengineering (Basel, Switzerland) · 2023
    Review
  9. Review
  10. Review
  11. Does atmospheric dimethyldiselenide play a role in reducing COVID-19 mortality?Gondwana research : international geoscience journal · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 15 institutions in 9 countries.

Jean BousquetDepartment of Dermatology and Allergy, Charité, Universitätsmedizin Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Comprehensive Allergy Center, Berlin, Germany. jean.bousquet@orange.fr.ORCID http://orcid.org/0000-0001-9226-7762
Jean-Paul CristolLaboratoire de Biochimie et Hormonologie, PhyMedExp, Université de Montpellier, INSERM, CNRS, CHU, Montpellier, France.
Wienczyslawa CzarlewskiMedical Consulting Czarlewski, Levallois, France.
Josep M AntoIMIM (Hospital del Mar Research Institute), Barcelona, Spain.
Adrian MartineauInstitute for Population Health Sciences, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Tari HaahtelaSkin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.
Susana C FonsecaGreenUPorto - Sustainable Agrifood Production Research Centre, DGAOT, Faculty of Sciences, University of Porto, Campus de Vairão, Vila do Conde, Portugal.
Guido IaccarinoDepartment of Advanced Biomedical Sciences, Federico II University, Napoli, Italy.
Hubert BlainDepartment of Geriatrics, Montpellier University Hospital, Montpellier, France.
Alessandro FiocchiDivision of Allergy, Department of Pediatric Medicine, The Bambino Gesu Children's Research Hospital Holy See, Rome, Italy.
G Walter CanonicaPersonalized Medicine Asthma and Allergy Clinic-Humanitas University & Research Hospital, IRCCS, Milano, Italy.
Joao A FonsecaCINTESIS, Center for Research in Health Technology and Information Systems, Faculdade de Medicina da Universidade do Porto; and Medida,, Lda Porto, Porto, Portugal.
Alain VidalWorld Business Council for Sustainable Development (WBCSD) Maison de la Paix, Geneva, Switzerland.
Hak-Jong ChoiMicrobiology and Functionality Research Group, Research and Development Division, World Institute of Kimchi, Gwangju, Korea.
Hyun Ju KimSME Service Department, Strategy and Planning Division, World Institute of Kimchi, Gwangju, Korea.
Vincent Le MoingMaladies Infectieuses et Tropicales, CHU, Montpellier, France.
Jacques ReynesMaladies Infectieuses et Tropicales, CHU, Montpellier, France.
Aziz SheikhThe Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
Cezmi A AkdisSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
Torsten ZuberbierDepartment of Dermatology and Allergy, Charité, Universitätsmedizin Berlin, Humboldt-Universität Zu Berlin, Berlin Institute of Health, Comprehensive Allergy Center, Berlin, Germany.
ARIA group
Charité - Universitätsmedizin Berlin · DEUniversidade do Porto · PTWorld Institute of Kimchi · KRAgroParisTech · FRBambino Gesù Children's Hospital · ITCentre National de la Recherche Scientifique · FRFederico II University Hospital · ITHumanitas University · ITInserm · FRQueen Mary University of London · GBUniversitat Pompeu Fabra · ESUniversité de Montpellier · FRUniversity of Edinburgh · GBUniversity of Helsinki · FIUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are large between- and within-country variations in COVID-19 death rates. Some very low death rate settings such as Eastern Asia, Central Europe, the Balkans and Africa have a common feature of eating large quantities of fermented foods whose intake is associated with the activation of the Nrf2 (Nuclear factor (erythroid-derived 2)-like 2) anti-oxidant transcription factor. There are many Nrf2-interacting nutrients (berberine, curcumin, epigallocatechin gallate, genistein, quercetin, resveratrol, sulforaphane) that all act similarly to reduce insulin resistance, endothelial damage, lung injury and cytokine storm. They also act on the same mechanisms (mTOR: Mammalian target of rapamycin, PPARγ:Peroxisome proliferator-activated receptor, NFκB: Nuclear factor kappa B, ERK: Extracellular signal-regulated kinases and eIF2α:Elongation initiation factor 2α). They may as a result be important in mitigating the severity of COVID-19, acting through the endoplasmic reticulum stress or ACE-Angiotensin-II-AT

Indexed as

COVID-19FoodsInsulin resistanceNrf2NutrientsObesityTRPA1

Identifiers

PMID33292691
PMCPMC7711617
OpenAlexW3110586950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.